Summaries of health policy coverage from major news organizations
GlaxoSmithKline to Cut Price of AIDS Drugs in Romania
GlaxoSmithKline PLC has signed an agreement with the Romanian Ministry of Health to cut by 30% to 87% the cost of its AIDS drugs in that country, AFX News reports. The price cut could "boost" access to AIDS drugs by 50% and could reduce the Health Ministry's expenses by $9.7 million, health officials said. Eighty percent of Romania's 8,461 AIDS cases are children, "making up more than half of Europe's minors with AIDS" (AFX News, 1/14).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.